Jing Jin

I obtained my PhD in Biomedical Sciences from the University of Bern, where I investigated the molecular pathways of autophagy in the pathogenesis of acute myeloid leukemia. Before joining NLO, I worked at the University R&D strategy department and Biotech company respectively. Because of my interest in science and technology, and experience in promoting academic, industrial collaboration, grant application and IP valuation, I became specifically interested in IP protection and how to make good use of innovation to create values for the benefit of our society and the environment.

Training & Education

• Basic Training Course on European Patent Law, CEIPI University of Strasbourg (2021)
• PhD in Biomedical Sciences, University of Bern (2016)
• MSc Interdisciplinary Approaches to Life Science, Paris Descartes University (2012)
• BSc in Biology Science, Minzu University of China (2010)
• Exchange student, Sookmyung Women’s University (2009)

Publications

• First author. Low Autophagy (ATG) Gene expression is associated with an immature AML blast cell phenotype and can be restored during AML differentiation therapy. Oxidative Medicine and Cellular Longevity. 2018
• Co-author. Linking the SUMO protease SENP5 to neutrophil differentiation of AML cells, Leukemia Research Reports. 2015
• Co-author. Human DMTF1β antagonizes DMTF1α regulation of the p14(ARF) tumor suppressor and promotes cellular proliferation. BBAGRM. 2015